Articles published by KalVista Pharmaceuticals, Inc.
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Second Fiscal Quarter Results
December 08, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 05, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals to Present at Upcoming Investor Conferences
November 07, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 02, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Announces Appointment of Brian J.G. Pereira, M.D. as Board Chairman
October 17, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Presents New Patient-Centric Data at 2022 HAEi Global Leadership Workshop
October 07, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 05, 2022
Via Business Wire
Tickers
KALV
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports First Fiscal Quarter Results
September 08, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
September 02, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
August 02, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Provides Operational Update and Fiscal Year Financial Results
July 07, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
July 05, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
June 03, 2022
Via Business Wire
Tickers
KALV
Via Business Wire
Tickers
KALV
Via Business Wire
Tickers
KALV
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals to Present at 21st Annual Needham Virtual Healthcare Conference
April 11, 2022
Via Business Wire
Tickers
KALV
KalVista Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
April 04, 2022
Via Business Wire
Tickers
KALV
KalVista Announces Publication of Additional KVD900 Data in Clinical & Experimental Allergy
March 22, 2022
Via Business Wire
Tickers
KALV
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.